Navigation Links
Aethlon Medical Discloses New HIV/AIDS Treatment Data
Date:5/5/2009

unications 858.459.7800 x302 jrichardson@aethlonmedical.com Jim Frakes Senior VP Finance 858.459.7800 x300 jfrakes@aethlonmedical.com

Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, the capability of the Hemopurifier(R) to reduce viral loads and other disease conditions, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the ability of the Company to obtain FDA and other regulatory approvals permitting the sale of its products, the Company's ability to manufacture its products and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings.


'/>"/>
SOURCE Aethlon Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Aethlon Medical Announces CEO Interview and Corporate Presentation Available Online
2. Aethlon Medical Announces Engagement of RedChip Companies to Initiate Investor and Media Relations Programs
3. Aethlon Medical Confirms Hemopurifier(R) Is a Treatment Candidate Against Swine Flu Virus
4. MSU engineering team designs innovative medical device
5. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
6. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
7. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
8. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
9. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
10. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
11. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... If proposed health care legislation is enacted, it ... system. Approximately 18.4 million Californians and 161 million ... employer-based insurance for their health care coverage. ... legislation entail specific requirements for employer-based insurance. ... firms that currently comply with most new standards, ...
(Date:12/16/2009)... Raises Significant Funds to Benefit of Children with Autism ... Taylor, Gary Cole and Zachary Levi Join Ben Stiller ... ANGELES, Dec. 16 At its 13th annual ... individuals. Hasbro President & CEO Brian ... in recognition of his far-reaching philanthropic leadership and commitment ...
(Date:12/16/2009)... -- Immucor, Inc. (Nasdaq: BLUD ), a global ... transfusion industry, today announced that Paul D. Mintz, M.D. ... independent director, effective January 1, 2010. ,, Dr. ... medicine for more than 30 years. He is a ... of Virginia School of Medicine. He also serves as ...
(Date:12/16/2009)... The most widely used human embryonic stem cell ... justice questions that must be addressed to ensure that ... according to a University of Michigan research team. ,, ... U-M team analyzed 47 embryonic stem cell lines, including ... researchers. The scientists determined the genetic ancestry of each ...
(Date:12/16/2009)... Scientists pinpoint seven that increase susceptibility to disease ... genes associated with increased susceptibility to leprosy have ... , The researchers, who analyzed more than 10,000 ... in China, said their discovery highlights the important ... the development of leprosy. , "Though leprosy is ...
Breaking Medicine News(10 mins):Health News:How National Health Reform Proposals Would Affect Employer-Based Plans in California 2Health News:How National Health Reform Proposals Would Affect Employer-Based Plans in California 3Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 2Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 3Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 4Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 5Health News:Immucor Appoints New Board Director 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 3Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 5Health News:Leprosy Genes Identified 2
... Hospital, Bangalore, have removed a large cancerous tumour from a ... statement that Prabhu Ram was diagnosed to be ailing from ... to difficulty in breathing, high fever and swelling of the ... arising from both the upper chambers of the heart, blocking ...
... Grunenthal GmbH presented the first clinical evidence for ... release) for patients suffering from chronic pain ... Against Rheumatism (EULAR), 13-16 June 2007, Barcelona, Spain. ... of its kind, combining two analgesic principles, mu-receptor ...
... Medicine have identified proteins in the rod and cones of ... genetic causes of a host of inherited eye diseases. ... goes wrong at the most basic level in these diseases ... have identified and measured the types and amounts of proteins ...
... protection from harmful rays emitted by the sun and people ... may even risk blindness, warn scientists in Britain. ,The ... radiation may severely affect the skin, eyes or the immune ... choose sunglasses purely on the basis of their price and ...
... pub hopes to benefit from the ban on smoking and ... the success of the ban. The Smoking ban, in public ... ample support from the public of Britain. Three quarter of ... looking for an opening in areas where smokers are most ...
... Dietary supplements pills, liquids or other products are ... is not exactly well-regulated. ,But now, addressing concerns ... supplements, the Food and Drug Administration has announced that it ... of all ingredients by the manufacturers themselves. ,Frequently ...
Other Medicine News:Health News:Phase II Data Show Efficacy and Tolerability of Tapentadol in Chronic Pain Treatment 2Health News:Phase II Data Show Efficacy and Tolerability of Tapentadol in Chronic Pain Treatment 3Health News:Genetic Cause of Inherited Eye Diseases Identified 2Health News:Wear Protective Sunglasses, Not Just for Style 2Health News:Pubs Propose to Sell Nicotine Gum Patches 2Health News:US FDA Wants Vitamin Manufacturers to Test All Ingredients 2
(Date:12/16/2009)... Dec. 16 Verathon®, maker of ... announce that portable bladder volume ultrasound is ... guidelines for the Prevention of Catheter-Associated Urinary ... guidelines, introduced in early November 2009, replace ... 1981. The guidelines are located on ...
(Date:12/16/2009)... Medical Technologies, Inc. today announced that its fully ... and interoperability solution, Prime Suite® 2011, won ... 2009 Top 20 Best in KLAS Awards: ... For practices having between six and 25 physicians, ... KLAS in ambulatory EMR for the fourth consecutive ...
(Date:12/16/2009)... BioSpecifics Technologies Corp. (Nasdaq: BSTC ... collagenase-based products, today announced top-line efficacy and safety ... XIAFLEX(TM) for the treatment of Peyronie,s disease. Peyronie,s ... collagen on the shaft of the penis, which ... difficult or impossible in advanced cases. The Phase ...
Breaking Medicine Technology:New 2009 CDC Guidelines for the Prevention of Catheter-Associated Urinary Tract Infections Include Bladder Volume Ultrasound 2New 2009 CDC Guidelines for the Prevention of Catheter-Associated Urinary Tract Infections Include Bladder Volume Ultrasound 3New 2009 CDC Guidelines for the Prevention of Catheter-Associated Urinary Tract Infections Include Bladder Volume Ultrasound 4New 2009 CDC Guidelines for the Prevention of Catheter-Associated Urinary Tract Infections Include Bladder Volume Ultrasound 5Greenway Medical Technologies' PrimeSuite Wins Three Best in KLAS Awards 2Greenway Medical Technologies' PrimeSuite Wins Three Best in KLAS Awards 3Greenway Medical Technologies' PrimeSuite Wins Three Best in KLAS Awards 4BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 2BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 3BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 4Potential Breakthrough Cancer Treatment Now Available From Vascular Designs 55989 1Potential Breakthrough Cancer Treatment Now Available From Vascular Designs 55989 2Potential Breakthrough Cancer Treatment Now Available From Vascular Designs 55989 3Potential Breakthrough Cancer Treatment Now Available From Vascular Designs 55989 4MarketsandMarkets 3A Global Biosimilars Product Market Worth 2419 4 Billion by 2014 13795 1MarketsandMarkets 3A Global Biosimilars Product Market Worth 2419 4 Billion by 2014 13795 2MarketsandMarkets 3A Global Biosimilars Product Market Worth 2419 4 Billion by 2014 13795 3New Technique Offers Hope for Kids With Immune Deficiency 55986 1New Technique Offers Hope for Kids With Immune Deficiency 55986 2
... within 2-6 hours of the first dose, according to published ... RAPAFLO (TM) (silodosin), a new, uniquely selective alpha ... BPH, produces rapid improvements of both irritative and obstructive urinary ... published in the June issue of The ...
... - Glivec(R) (imatinib) Now Approved in the UK for ... are at Significant Risk of the Cancer Returning After Surgery(1) ... Surgery Significantly Reduces Risk of Cancer,Relapse(2) , ... Experience Their,Cancer Returning Within Two Years(3,4) , ...
Other Medicine Technology:RAPAFLO(TM) (silodosin) Provides Rapid and Sustained Benign Prostatic Hyperplasia (BPH) Symptom Relief in as Little as Three Days 2RAPAFLO(TM) (silodosin) Provides Rapid and Sustained Benign Prostatic Hyperplasia (BPH) Symptom Relief in as Little as Three Days 3RAPAFLO(TM) (silodosin) Provides Rapid and Sustained Benign Prostatic Hyperplasia (BPH) Symptom Relief in as Little as Three Days 4RAPAFLO(TM) (silodosin) Provides Rapid and Sustained Benign Prostatic Hyperplasia (BPH) Symptom Relief in as Little as Three Days 5Glivec(R) is the First Adjuvant Treatment Approved in the UK to Delay Return of Gastrointestinal Cancer After Surgery 2Glivec(R) is the First Adjuvant Treatment Approved in the UK to Delay Return of Gastrointestinal Cancer After Surgery 3Glivec(R) is the First Adjuvant Treatment Approved in the UK to Delay Return of Gastrointestinal Cancer After Surgery 4Glivec(R) is the First Adjuvant Treatment Approved in the UK to Delay Return of Gastrointestinal Cancer After Surgery 5Glivec(R) is the First Adjuvant Treatment Approved in the UK to Delay Return of Gastrointestinal Cancer After Surgery 6
... Liquichek™ Reticulocyte Stain is ... stain for use in manual ... liquid product has a one ... at 230C and can be ...
Seroconversion and Antigen Panel Chart...
... CT/GC Controls are liquid controls ... of test procedures that detect ... Since they are specimen specific, ... either urine or endocervical/urethral swabs ...
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays....
Medicine Products: